LC
GILD icon

Lindbrook Capital’s Gilead Sciences GILD Stock Holding History

Lindbrook Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$613K Buy
5,469
+884
+19% +$91.2K 0.06% 193
2024
Q4 		$424K Buy
4,585
+403
+10% +$36.3K 0.04% 246
2024
Q3 		$351K Buy
4,182
+382
+10% +$29.1K 0.03% 276
2024
Q2 		$261K Buy
3,800
+929
+32% +$62K 0.02% 307
2024
Q1 		$210K Sell
2,871
-398
-12% -$30.6K 0.02% 351
2023
Q4 		$265K Buy
3,269
+883
+37% +$68.7K 0.03% 296
2023
Q3 		$179K Sell
2,386
-222
-9% -$17.1K 0.02% 345
2023
Q2 		$201K Buy
2,608
+195
+8% +$15.6K 0.02% 324
2023
Q1 		$200K Sell
2,413
-5,669
-70% -$470K 0.02% 312
2022
Q4 		$694K Buy
8,082
+6,717
+492% +$532K 0.09% 148
2022
Q3 		$84K Buy
1,365
+226
+20% +$14.3K 0.01% 491
2022
Q2 		$70K Sell
1,139
-6,131
-84% -$380K 0.01% 547
2022
Q1 		$432K Buy
7,270
+303
+4% +$19.4K 0.07% 178
2021
Q4 		$506K Buy
6,967
+34
+0.5% +$2.34K 0.08% 165
2021
Q3 		$484K Buy
6,933
+28
+0.4% +$1.97K 0.13% 71
2021
Q2 		$475K Sell
6,905
-36
-0.5% -$2.4K 0.11% 83
2021
Q1 		$449K Buy
6,941
+976
+16% +$62.9K 0.1% 82
2020
Q4 		$348K Buy
5,965
+17
+0.3% +$1.03K 0.09% 96
2020
Q3 		$376K Sell
5,948
-599
-9% -$41.5K 0.1% 83
2020
Q2 		$504K Sell
6,547
-105
-2% -$8.05K 0.15% 51
2020
Q1 		$497K Buy
6,652
+278
+4% +$19.2K 0.19% 44
2019
Q4 		$414K Sell
6,374
-30
-0.5% -$1.95K 0.14% 71
2019
Q3 		$406K Sell
6,404
-1,929
-23% -$126K 0.15% 65
2019
Q2 		$562K Buy
8,333
+1,344
+19% +$88.4K 0.22% 42
2019
Q1 		$454K Buy
6,989
+133
+2% +$8.84K 0.18% 56
2018
Q4 		$428K Buy
+6,856
New +$479K 0.21% 51

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Lindbrook Capital's GILD Position: Q1 2025 in Review

Lindbrook Capital increased its Gilead Sciences (GILD) stake by 19% in Q1 2025, buying an estimated $91.2K and bringing the position to 5,469 shares worth $613K. The position accounts for 0.06% of the portfolio, ranked #193.

Lindbrook Capital first reported a position in GILD in Q4 2018 and has held it in 26 quarters since. The position peaked at $694K in Q4 2022. 2,014 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

  • Lindbrook Capital held 5,469 shares of Gilead Sciences worth $613K as of Q1 2025.
  • Lindbrook Capital bought 884 Gilead Sciences shares in Q1 2025, an estimated $91.2K.
  • Gilead Sciences made up 0.06% of Lindbrook Capital's portfolio in Q1 2025, its #193 holding.
  • Lindbrook Capital first reported a position in Gilead Sciences in Q4 2018 and has held it in 26 quarters since.
  • Lindbrook Capital's Gilead Sciences position peaked at $694K in Q4 2022.
  • 2,014 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.